Protective effect of Geraniol (cas 106-24-1) on the transgenic Drosophila model of Parkinson’s disease
-
Add time:08/25/2019 Source:sciencedirect.com
The role of Geraniol (cas 106-24-1) was studied on the transgenic Drosophila model flies expressing normal human alpha synuclein (h-αS) in the neurons. Geraniol at final concentration of 10, 20 and 40 μM were mixed in the diet and the flies were allowed to feed on it for 24 days. The effect of geraniol was studied on the climbing ability, activity pattern, lipid peroxidation, protein carbonyl, glutathione, dopamine content, and glutathione-S-transferase activity in the brains of transgenic Drosophila. The exposure of PD model flies to 10, 20 and 40 μM of geraniol results in a significant delay in the loss of climbing ability (p < 0.05), improved activity pattern reduced the oxidative stress (p < 0.05) in the brains of transgenic Drosophila as compared to unexposed PD model flies. The results suggest that geraniol is potent in reducing the PD symptoms in transgenic Drosophila model of Parkinson’s disease.
We also recommend Trading Suppliers and Manufacturers of Geraniol (cas 106-24-1). Pls Click Website Link as below: cas 106-24-1 suppliers
Prev:Original articleGeraniol (cas 106-24-1) alleviates diabetic cardiac complications: Effect on cardiac ischemia and oxidative stress
Next:Effect of Geraniol (cas 106-24-1) on performance, emission and combustion characteristics of CI engine fuelled with gutter oil obtained from different sources) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Transcriptome analysis and targeted metabolic profiling for pathway elucidation and identification of a Geraniol (cas 106-24-1) synthase involved in iridoid biosynthesis from Gardenia jasminoides08/27/2019
- Effect of Geraniol (cas 106-24-1) on performance, emission and combustion characteristics of CI engine fuelled with gutter oil obtained from different sources08/26/2019
- Original articleGeraniol (cas 106-24-1) alleviates diabetic cardiac complications: Effect on cardiac ischemia and oxidative stress08/24/2019
- In vitro and in vivo biofilm inhibitory efficacy of Geraniol (cas 106-24-1)-cefotaxime combination against Staphylococcus spp.08/23/2019
- Thymoquinone and Geraniol (cas 106-24-1) alleviate cisplatin-induced neurotoxicity in rats through downregulating the p38 MAPK/STAT-1 pathway and oxidative stress08/22/2019
- Manipulation of GES and ERG20 for Geraniol (cas 106-24-1) overproduction in Saccharomyces cerevisiae08/21/2019
- Regular articleAn enzyme-coupled assay enables rapid protein engineering for Geraniol (cas 106-24-1) production in yeast08/20/2019
- The potential of Geraniol (cas 106-24-1) to reduce cytotoxic and genotoxic effects of MNNG in plant and human lymphocyte test-systems08/19/2019
- Protective activity of Geraniol (cas 106-24-1) against acetic acid and Helicobacter pylori- induced gastric ulcers in rats08/18/2019